These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Recognition and management of heparin-induced thrombocytopenia (HIT) and thrombosis. Alving BM; Krishnamurti C Semin Thromb Hemost; 1997; 23(6):569-74. PubMed ID: 9469632 [TBL] [Abstract][Full Text] [Related]
17. [Heparin-induced trombocytopenia: pathogenesis, clinical manifestations and management in hemodialysis]. Esposito P; Libetta C; Borettaz I; Barone M; Canevari M; Martinelli C; Montagna F; Romeo S; Margiotta E; Calatroni M; La Porta E; Dal Canton A G Ital Nefrol; 2014; 31(3):. PubMed ID: 25030007 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of a new automated panel of assays for the detection of anti-PF4/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia. Legnani C; Cini M; Pili C; Boggian O; Frascaro M; Palareti G Thromb Haemost; 2010 Aug; 104(2):402-9. PubMed ID: 20539902 [TBL] [Abstract][Full Text] [Related]
20. When heparin causes thrombosis: significance, recognition, and management of heparin-induced thrombocytopenia in dialysis patients. Chang JJ; Parikh CR Semin Dial; 2006; 19(4):297-304. PubMed ID: 16893407 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]